Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL)

K-Number: K161510 · 2017-02-13

Decision Date2017-02-13
Product CodeLON
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) is a medical device manufactured by bioMerieux, Inc.. It received FDA 510(k) clearance on 2017-02-13 under approval number K161510. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL)?

VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) is a medical device that received FDA 510(k) clearance on 2017-02-13. It is manufactured by bioMerieux, Inc.. The 510(k) number is K161510.

When was VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) approved by the FDA?

VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) received FDA 510(k) clearance on 2017-02-13, under approval number K161510.

What company makes VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL)?

VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) is manufactured by bioMerieux, Inc..

What is the FDA product code for VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL)?

The FDA product code for VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) is LON.

Other Devices by bioMerieux, Inc.

View all 66 devices →

Related Devices (Code: LON)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.